You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 
  1. EVENTS - 31-03-2014

    Award in the US for efforts to support hemophilia patients communities

    Kedrion’s Vice-President of North American Commercial Operations is “Man of the Year” for the Hemophilia Association of New Jersey

    read more 
  2. EVENTS - 11-02-2014

    Conference in Colombia: Professor Mannucci on the future of hemophilia

    The event, open to industry experts, patients’ associations and the scientific community, took place in Medellín on February 12th, 2014

    read more 
  3. PLASMA & BIOTHERAPIES - 27-11-2013

    Distribution of the first recombinant Factor VIII from human cells

    Kedrion to be the distributor in Italy over the next ten years. The indication is the treatment of…

    read more 
  4. CORPORATE - 11-11-2013

    Kedrion and La Kelley Communication for a donation in Pakistan

    500,000 IU of Factor IX shipped to the Pakistan Hemophilia Patients Welfare Society Rawalpindi.

    read more 

Pages

For more information please contact: pressoffice@kedrion.com